O-RAN-ALLIANCE
14.7.2022 17:07:08 CEST | Business Wire | Press release
O-RAN ALLIANCE:
52 O-RAN Specifications Published since March 2022
O-RAN ALLIANCE has published a new set of 52 specifications for open and intelligent RAN, as the first batch of the O-RAN Release 003 specifications. Among them there are 12 new titles including use cases for Massive MIMO and the R1 interface, E2 interface testing, O2dms interface, Acceleration Abstraction Layer, outdoor macro cell HW, and security specification of 3 different parts of the O-RAN Architecture.
“The O-RAN ALLIANCE has always taken security very seriously. We have recently converted the Security Focus Group into O-RAN’s 11th technical Work Group to allow even more intensive specification efforts in the field of security,” said Andre Fuetsch, Chairman of the O-RAN ALLIANCE and Chief Technology Officer of AT&T. “Security experts from the O-RAN ecosystem have been applying systematic threat analysis on different components of the O-RAN Architecture. Security is becoming an integral part of individual interface or function specifications and there is a security testing specification for proper verification. A systematic and transparent approach to security by the broad O-RAN ecosystem follows best practices seen in other parts of the network to ensure the best possible, most secure solutions.”
Another 40 technical documents have been updated with extensions and new features.
To learn more about the new and updated specifications, please read our web announcement . To access the O-RAN specifications, please visit our website .
6th Release of Open Software for the RAN – “F” – Delivered by the O-RAN Software Community
In June 2022, following on the half year release cycle, the O-RAN Software Community (OSC) published its 6th open software release dubbed "F". The F Release continues to improve the support for Traffic Steering and Network Slicing use cases, as well as the alignment with the latest O-RAN specifications.
Main features of the F release include:
- For O-Cloud, the OSC O-CLOUD platform implemented O2 DMS and IMS, and support of 3 types of resource pools (SIMPLEX, DUPLEX, and DUPLEX +) according to the O-RAN O-CLOUD specification
-
For Intelligence, the F release delivered:
- Implementation of A1-Policy & A1-EI functions according to O-RAN specifications
- Initial R1 interface support such as Data Management Exposure
- Update of the Near-RT RIC to support E2AP specification v2.0
- xApp framework for Python with support of the REST-based interface for E2 subscriptions
- For the radio protocol, new features include Intra-CU handover, Idle Mode Paging and HARQ framework in a new version
- The Service Management and Orchestration (SMO) added its management enhancement by supporting the Standard Defined Messages (StdDefine) over the O1/VES interface, while developing the framework for Network Slicing, and support for the O2 interface
- Tools and functions to provide the O-RAN deployment topology view for rApp and CNF deployment
"Congratulations to the team for continuously progressing at the pace of 2-release cycle per year since its inception in 2019," said Chih-Lin I, co-chair of O-RAN Technical Steering Committee, and Chief Scientist from China Mobile. "One of the key highlights from F release is the implementation of the O-CLOUD with multiple resources, which becomes the steppingstone to Service Management and Orchestration (SMO) xNF deployment for the G release."
“Ericsson continues to actively engage in the O-RAN ALLIANCE and O-RAN Software Community,” said Per Beming, VP Head of Standard & Industry Initiatives at Ericsson. “We recognise the potential for an ecosystem of multi-vendor rApps which support service providers in deploying, evolving, optimizing and automatically healing the RAN. We imagine a world in which simple multi-vendor rApps are used to build complex use cases and recognize the importance of the R1 interface in enabling this vision. As the main contributor to the Non-Realtime RIC project in OSC F release, Ericsson has focused on the challenges involved in exposing services over the R1 interface, in addition to elaborating an approach to rApp life cycle management.”
To deep-dive into the F release and to get the open software, please visit the O-RAN Software Community website .
1st Certificates Awarded in the O-RAN Certification and Badging Program by Asian OTICs
The first two O-RAN Certificates have been awarded, validating the establishment of the O-RAN Certification and Badging Program.
O-RAN ALLIANCE announced its Certification and Badging Program in June 2022, in cooperation with Open Testing and Integration Centers (OTIC). O-RAN Certification and Badging Program represents a comprehensive mechanism ensuring confidence in O-RAN solutions within the industry.
O-RAN certificates state that an equipment or function is conformant to O-RAN specifications, whereas O-RAN badges confirm interoperability or end-to-end functionality of an O-RAN solution.
O-RAN ALLIANCE maintains a Catalogue of O-RAN Certificates and Badges at its website .
The Asia & Pacific Open Test and Integration Center (OTIC) in China PRC issued the O-RAN Conformance Certification at the end of June 2022. The certification was awarded to an O-RU that fully meets the O-RAN WG4 Open Fronthaul (OFH) technical specifications, including the Control, User, and Synchronization plane (CUS-Plane) and the Management-plane (M-Plane). The complete process consisted of two phases, namely the pre-tests and the official verification, with all 31 test cases verified and passed.
Another O-RAN RU certification testing took place in the Auray OTIC and Security Lab. During the O-RAN Global PlugFest Spring 2022, the OTIC completed OFH conformance certification by conducting the required tests following the process and procedure specified by the O-RAN ALLIANCE. Auray OTIC and Security Lab also obtained TAF ISO/IEC 17025 approval for O-RAN test specifications and follows ISO/IEC 17065 to add independent peer viewer procedure.
Both awarded RUs are ready for commercial deployment for Tier one and other operators.
Upon approval by the O-RAN ALLIANCE, each OTIC provides collaborative, open, and impartial working environment to ensure consistency and quality of testing of O-RAN products and solutions.
All approved OTICs are fully ready to support the O-RAN Certification and Badging Program. Companies that want to apply for O-RAN Certificate or Badge may choose to contact any OTIC according to its specialization or region. Visit our website to see all available OTICs.
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of more than 340 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN specifications enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information, please visit www.o-ran.org .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220714005600/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom